Cytokine patterns during progression to AIDS in children with perinatal HIV infection.
Patterns of cytokine expression were analyzed in polyclonal and antigenic responses in children with perinatal HIV infection. Responses of PBL to PMA and A23187 calcium ionophore studied in patients in different stages of HIV infection revealed reduced levels of IL-2 in HIV-infected children beginning before 6 mo of age, and age-dependent increases in expression of IL-4, IL-10, and IFN-gamma. The levels of IL-4, IL-10, and IFN-gamma expression did not differ significantly between HIV-infected and age-matched uninfected children of HIV-seropositive mothers, except for a small reduction in HIV-infected children in late stages of infection. Responses to PHA, HLA alloantigens, HIV envelope peptides T1 and P18, and tetanus toxoid were studied in PBMC derived from asymptomatic and mildly symptomatic HIV-infected children. IL-2, IFN-gamma, IL-4, and IL-5 expression was detected in PHA-stimulated PBMC from all analyzed patients. HIV-infected children who failed to respond to HLA alloantigens, tetanus toxoid, or the envelope peptides had lower numbers of CD4+ cells and expressed, on PHA stimulation, higher levels of IL-4 and IL-5 and lower levels of IL-2 and IFN-gamma than patients who responded to the antigenic stimulation. Results of these analyses suggest that cytokine expression in HIV-infected children depends on the character of the stimuli as well as the phenotype of PBMC, and indicate possible prevalence of Th2 Ag-specific responses during the progression of HIV-induced immunodeficiency.
Hyjek
E
E
Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Lischner
H W
HW
Hyslop
T
T
Bartkowiak
J
J
Kubin
M
M
Trinchieri
G
G
Kozbor
D
D
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D016207:Cytokines / Q000032:analysis / Q000378:metabolism*; D018450:Disease Progression; D005260:Female; D015658:HIV Infections / Q000276:immunology*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D015759:Ionomycin / Q000494:pharmacology; D008213:Lymphocyte Activation; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology*; D011446:Prospective Studies; D012333:RNA, Messenger / Q000032:analysis; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D018417:Th1 Cells / Q000378:metabolism*; D018418:Th2 Cells / Q000378:metabolism*
D016207:Cytokines; D012333:RNA, Messenger; D015759:Ionomycin; D013755:Tetradecanoylphorbol Acetate